KLEMA CATHY
Insider CIK 1181157 · OPRX Director · ACT Director · WPI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | A Award | 2026-06-09 | 2026-06-10 | 34,517 | — | $0 | 56,137 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2025-06-11 | 2025-06-12 | 9,868 | — | $0 | 21,620 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-02-02 | 2025-02-04 | 5,109 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-02-02 | 2025-02-04 | 5,109 | — | $0 | 11,752 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-06-07 | 2024-06-11 | 6,643 | — | $0 | 6,643 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2024-02-02 | 2024-02-06 | 5,109 | — | $0 | 5,109 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-04-30 | 2019-05-02 | 953 | $147.00 | $140.1K | 25,081 | SEC↗ |
| AGN Allergan plc | J Other | 2019-03-11 | 2019-03-13 | 410 | — | $0 | 26,034 | SEC↗ |
| AGN Allergan plc | A Award | 2018-05-02 | 2018-05-04 | 1,985 | $151.07 | $299.9K | 25,624 | SEC↗ |
| AGN Allergan plc | A Award | 2017-05-04 | 2017-05-05 | 1,223 | $245.25 | $299.9K | 23,639 | SEC↗ |
| AGN Allergan plc | A Award | 2016-08-08 | 2016-08-09 | 201 | $248.31 | $49.9K | 22,416 | SEC↗ |
| AGN Allergan plc | A Award | 2016-05-05 | 2016-05-09 | 1,188 | $210.34 | $249.9K | 22,215 | SEC↗ |
| ACT Actavis plc | A Award | 2015-06-05 | 2015-06-08 | 826 | $302.30 | $249.7K | 21,027 | SEC↗ |
| AGN Allergan plc | A Award | 2015-06-05 | 2015-06-30 | 826 | $302.30 | $249.7K | 21,027 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-06-04 | 2015-06-08 | 549 | $303.38 | $166.6K | 20,201 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-06-04 | 2015-06-30 | 549 | $303.38 | $166.6K | 20,201 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 1,142 | $197.05 | $225.0K | 20,750 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 19,608 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 19,608 | — | $0 | 19,608 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-12 | 2013-08-14 | 1,667 | $133.03 | $221.8K | 19,608 | SEC↗ |
| ACT Actavis, Inc. | G Gift | 2013-08-09 | 2013-08-14 | 3,334 | — | $0 | 21,275 | SEC↗ |
| ACT Actavis, Inc. | G Gift | 2013-08-06 | 2013-08-14 | 5,000 | — | $0 | 24,609 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-05-10 | 2013-05-14 | 1,877 | — | $0 | 29,609 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-07-31 | 2012-08-01 | 5,000 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-07-31 | 2012-08-01 | 5,000 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-07-31 | 2012-08-01 | 11,700 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-07-31 | 2012-08-01 | 5,000 | $30.12 | $150.6K | 44,432 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-07-31 | 2012-08-01 | 11,700 | $44.14 | $516.4K | 39,432 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-07-31 | 2012-08-01 | 5,000 | $29.03 | $145.2K | 49,432 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-07-31 | 2012-08-01 | 11,700 | $78.38 | $917.0K | 37,732 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-07-31 | 2012-08-01 | 5,000 | $78.38 | $391.9K | 32,732 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-07-31 | 2012-08-01 | 5,000 | $78.38 | $391.9K | 27,732 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-05-11 | 2012-05-14 | 2,887 | — | $0 | 27,732 | SEC↗ |